Generic Price-Fixing Lawsuit Grows As More Companies, Two Executives Named Defendants

US state attorneys general name executives from Mylan and Emcure as defendants, and list may further expand as investigation continues into additional companies and drugs.

Gavel

Expansion of a US generic drug price-fixing lawsuit brought by 46 states and territories seems likely to continue even after the addition of 12 companies and two executives as defendants.

"Our ongoing investigation continues to uncover additional evidence, and we anticipate bringing more claims involving additional companies and drugs at...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Generics

More from Biosimilars & Generics